AstraZeneca Pharma India gets CDSCO approval for Enhertu for new breast cancer indication Ruchika Sharma9 May 2025 3:31 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate...
AstraZeneca-Daiichi Sankyo Enhertu recommended for approval in EU for patients with HER2-low or HER2-ultralow metastatic breast cancer Ruchika Sharma3 March 2025 12:15 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union...
AstraZeneca-Daiichi Sankyo Enhertu gets USFDA approval for HER2-ultralow metastatic breast cancer Ruchika Sharma28 Jan 2025 2:30 PM ISTAstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with...
USFDA grants priority review to AstraZeneca-Daiichi Sankyo Enhertu for HER2-low, HER2 Ultralow Breast Cancer Ruchika Sharma3 Oct 2024 9:15 AM ISTAstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and...
GST rates slashed for certain cancer drugs Yakshi Chugh10 Sept 2024 5:20 PM ISTNew Delhi: In an effort to reduce the overall cost for the treatment of cancer, the GST Council decided to reduce the GST rate on certain cancer drugs...
Health Bulletin 10/ September/ 2024 Yakshi Chugh10 Sept 2024 5:17 PM ISTHere are the Top health stories for the day: MCC NEET PG counselling 2024 tentative schedule out, registrations from Sept 20New Delhi- The...
GST rates reduced from 12 percent to 5 per cent on certain cancer drugs Ruchika Sharma10 Sept 2024 2:36 PM ISTNew Delhi: In an effort to reduce the overall cost for the treatment of cancer, the GST Council decided to reduce the GST rate on certain cancer...
AstraZeneca-Daiichi Sankyo Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer Ruchika Sharma15 Aug 2024 10:30 AM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has received conditional approval in China as a monotherapy for...
Health Bulletin 24/ July/ 2024 Anshika Mishra24 July 2024 4:26 PM ISTHere are the top health news for the day:Chandipura virus: More than 32 dead in worst outbreak in over 20 yearsThe worst outbreak of the Chandipura...
Health experts hail Centre move to exempt 3 more cancer drugs from Customs duty Ruchika Sharma24 July 2024 4:14 PM ISTNew Delhi: Health experts expressed appreciation on Tuesday for the central government's decision to exempt three additional cancer drugs from...
Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu Ruchika Sharma12 April 2024 12:54 PM ISTTucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...
AstraZeneca-Daiichi Sankyo Enhertu gets USFDA accelerated nod for metastatic HER2-positive solid tumours Ruchika Sharma7 April 2024 11:30 AM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients...
